Herbal medicine: The science of the art

Proceedings of the Nutrition Society

Volumn 65, Issue 2, 2006, Pages 145-152

  Walker, Ann F ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

Complementary medicine; Herbal medicine; Integrated medicine; Phytotherapy

Indexed keywords

CRATAEGUS EXTRACT; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; PLANT MEDICINAL PRODUCT;

AMNESIA; ANTIINFLAMMATORY ACTIVITY; ANTIVIRAL ACTIVITY; ATHEROSCLEROSIS; CHRONIC DISEASE; CHRONIC FATIGUE SYNDROME; CLINICAL TRIAL; CONFERENCE PAPER; CRATAEGUS; GINKGO BILOBA; HEART DISEASE; HERBAL MEDICINE; HOMEOSTASIS; HUMAN; HYPERICUM PERFORATUM; HYPERTENSION; META ANALYSIS; NUTRITIONAL SCIENCE; OBSERVATIONAL STUDY; PHYTOTHERAPY; SABAL; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION;

CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; GINKGO BILOBA; HUMANS; HYPERICUM; LIFE STYLE; MEDICINE, HERBAL; META-ANALYSIS; PHYTOTHERAPY; SERENOA;

GINKGO BILOBA; HYPERICUM PERFORATUM; SERENOA REPENS;

EID: 33744478639     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2006487     Document Type: Conference Paper

References (26)

1. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J & Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Journal of Rheumatology 15, 1833-1840.
2. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A & Ngu M (1998) Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. Journal of the American Medical Association 280, 1585-1589.
3. Birks J, Grimley EV & Van Dongen M (2002) Ginkgo Bilobafor Cognitive Impairment and Dementia. The Cochrane Database of Systematic Reviews 2002, issue 4, art. no. CD003120. Chichester, West Sussex: John Wiley & Sons Ltd.
4. Bone K (2003) A Clinical Guide to Blending Liquid Herbs: Herbal Formulations for the Individual Patient. Edinburgh: Churchill Livingstone.
5. Boyle P, Robertson C, Lowe F & Roehrborn C (2004) Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. British Journal of Urology International 93, 751-756.
6. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E & Whitehead WE (editors) (1994) The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology, and Treatment - A Multinational Consensus. Boston, MA: Little, Brown & Co.
7. European Commission (2004) Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004, amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union L136, 85-90.
8. European Scientific Cooperative on Phytotherapy (2003) Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd ed. New York: Thieme.
9. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG & Komaroff A (1994) The chronic fatigue syndrome: a comprehensive approach to its definition and study. Annals of Internal Medicine 121, 953-959.
10. Griggs B (1997) New Green Pharmacy: Story of Western Herbal Medicine. London: Vermilion.
11. Jouad H, Lemhadri A, Maghrani M, Burcelin R & Eddouks M (2003) Hawthorn evokes a potent anti-hyperglycemic capacity in streptozotocin-induced diabetic rats. Journal of Herbal Pharmacotherapy 3, 19-29.
12. Kasper S & Dienel A (2002) Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology 164, 301-308.
13. Linde K, Berner M, Egger M & Mulrow C (2005) St John's wort for depression: meta-analysis of randomised controlled trials. British Journal of Psychiatry 186, 99-107.
14. Mills S & Bone K (2000) Principles and Practice of Phytotherapy. Edinburgh: Churchill Livingstone.
15. Nicolaou N & Johnston GA (2004) The use of complementary medicine by patients referred to a contact dermatitis clinic. Contact Dermatitis 51, 30-33.
16. Paterson C (1996) Measuring outcomes in primary care: a patient generated measure, MYMOP, compared with the SF-36 health survey. British Medical Journal 312, 1016-1020.
17. Rigelsky JM & Sweet BV (2002) Hawthorn: pharmacology and therapeutic uses. American Journal of Health-System Pharmacy 59, 417-422.
18. Sacks FM, Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP et al. (1999) A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study. Clinical Cardiology 22, Suppl., 1116-1110.
19. Tankanow R, Tamer HR, Streetman DS, Smith SG, Welton JL, Annesley T, Aaronson KD & Bleske BE (2003) Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha). Journal of Clinical Pharmacology 43, 637-642.
20. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D & Dougados M (2005) Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Annals of Rheumatic Diseases 64, 29-33.
21. UK Parliament (1977) The Medicines Act 1968. Order 1977. Statutory Instrument 1977 No. 2128 (C. 71). London: H. M. Stationery Office.
22. Walker AF, Marakis G, Morris AP & Robinson PA (2002) Promising hypotensive effect of hawthorn extract: a randomized double-blind pilot study of mild, essential hypertension. Phytotherapy Research 16, 48-54.
23. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M & Simpson HCR (2006) Hypotensive effects of hawthorn for diabetic subjects taking prescription drugs: a RCT. British Journal of General Practice (In the Press).
24. Williamson EM (2001) Synergy and other interactions in phytomedicines. Phytomedicine 8, 401-409.
25. Williamson EM (2003) Potter's Herbal Cyclopaedia. Saffron Waiden, Essex: C W Daniel Co Ltd.
26. Wilt T, Ishani A, MacDonald R, Stark G, Mulrow C & Lau J (2000) Beta-Sitosterols for Benign Prostatic Hyperplasia. Cochrane Database of Systematic Reviews 1999, issue 3, art. no. CD001043. Chichester, West Sussex: John Wiley & Sons Ltd.